Why Cardinal Health, Inc. (CAH) stock moved
Cardinal Health, Inc. (CAH) shares fell 0.4% to $225.38 as of September 18, 2026, a slight decline from the prior close of $226.34. BestStocks flagged the session as a major change for CAH. Below, we break down what changed for CAH, why it matters for investors, how the stock reacted, and the catalysts on the calendar.
CAH fell 0.4% to $225.38
Cardinal Health fell 2.01% to $227.85 on light volume (0.69x average), likely driven by lingering concerns over IRA pricing pressures on pharmaceutical revenues. A September 2024 Zacks analysis highlighted the company's exposure to pricing headwinds, though management has emphasized cost mitigation through compensation agreements and distribution partnerships. The stock's intraday decline occurred on below-average trading interest, suggesting cautious positioning ahead of earnings. Cardinal Health earnings scheduled for 2026-10-30; consensus EPS estimate is $2.88. Watch for management commentary on IRA pricing impact and margin-protection initiatives.
What it means for Cardinal Health, Inc. investors
For Cardinal Health, Inc. investors, the recent signals add up to a bearish shift. On the constructive side: Positive price momentum; Positive price momentum. Weighing against that: Negative session, down 0.4%; Cardinal Health fell 2.01% to $227.85 on light volume (0.69x average), likely driven by lingering concerns over IRA pricing pressures on pharmaceutical revenues. Wall Street's consensus price target sits at $273.22, implying +21.2% upside from $225.38. BestStocks rates the overall signal quality low (43/100). With earnings roughly 41 days out, the next report is the most likely near-term test of the move.
CAH price reaction
CAH last traded at $225.38, down $0.96 (-0.42%) from the previous close of $226.34. The session traded on 1.9× average volume (above avg), so the move carried above-average conviction. Over the past month the stock has ranged between $225.38 and $248.61, and it currently sits about 0% of the way up that band.
Bullish and bearish analyst opinions on Cardinal Health, Inc. (CAH)
The consensus analyst price target on Cardinal Health, Inc. (CAH) is $273.22, 21.2% above the recent $225.38. Over the past 90 days analysts logged 0 upgrades, 15 maintains, and 0 downgrades. Here is how the bullish and bearish cases on CAH line up.
The bullish case
- Wall Street's consensus price target of $273.22 implies +21.2% upside from $225.38.
- The Street's most bullish target is $292.00 (+29.6%).
- Positive price momentum.
The bearish case
- Negative session, down 0.4%.
- Cardinal Health fell 2.01% to $227.85 on light volume (0.69x average), likely driven by lingering concerns over IRA pricing pressures on pharmaceutical revenues.
- Cardinal Health, Inc. (CAH) moved -2.88% from $227.09 to $220.54 on 2026-07-22.
Weighing both sides, BestStocks' composite read of recent signals is bearish, as the bull-versus-bear meter above shows. This is an educational summary of the bull and bear case, not investment advice.
Analyst price targets and ratings are FMP consensus figures as of Sep 18, 2026; other aggregators may differ. High and low targets show the range of estimates, not forecasts.
Previous notable changes for CAH
Frequently asked questions about CAH
Why did Cardinal Health, Inc. (CAH) stock move?
CAH fell 0.4% to $225.38. The move coincided with the context summarized above, though no single company-specific catalyst was independently confirmed.
How much did CAH stock fall?
CAH lost 0.42% ($0.96) versus the prior close of $226.34, last trading at $225.38 on 1.9× average volume.
When is Cardinal Health, Inc.'s next earnings date?
CAH's next earnings report is estimated for 2026-10-29 — about 41 days away.
What is the analyst price target for CAH?
The consensus analyst price target for CAH is $273.22, about 21.2% above the current $225.38. Over the past 90 days, analysts recorded 0 upgrades, 15 maintains, and 0 downgrades.
How BestStocks tracks CAH
This page is generated automatically by BestStocks' change-detection system after its price and volume cleared CAH-specific materiality thresholds, triggering an evidence check. It draws on 15 tracked change events for CAH, cross-checked against the data sources listed below. Price, volume, and market-capitalization figures are the live intraday quote as of September 18, 2026 and refresh as new information is detected; for companies with multiple share classes, market-cap figures can differ by data source. Analyst price targets and ratings are FMP consensus. This is an educational summary of what changed and why — not personalized investment advice.